Tag

Clair Record Archives - Carey Danis & Lowe

Zoloft Lawsuit News: Injured Parties Continue to File Zoloft Birth Defects Lawsuits

By | Pharmaceutical litigation, Uncategorized, Zoloft

zoloft_heart_birth_defect_ssri_pregnancyAs a national law firm representing individuals in Zoloft birth defects lawsuits, Carey Danis & Lowe has closely been watching for news and updates in Zoloft lawsuits. Earlier this month, a plaintiff filed a Zoloft birth defects lawsuit in St. Clair County Circuit Court in Illinois claiming that her child was born with congenital heart defects. The plaintiff filed her Zoloft lawsuit citing that the maker of Zoloft, Pfizer, did not provide adequate warning about the risks associated with Zoloft use during pregnancy.

In response to the lawsuit, a Pfizer spokesperson was quoted in the Madison-St. Clair Record as saying that the pharmaceutical company intends to defend itself against the charges.

 Zoloft Birth Defects Background

In a study published in 2007 in the New England Journal of Medicine, researchers concluded that taking Zoloft (sertraline) during the first trimester of pregnancy led to two times the risk of the baby being born with a heart defect, especially a hole in the heart. In addition, the study found that the risk of a baby developing omphalocele was 5.7 times higher when exposed to Zoloft in the womb.

An atrial septal defect, also called a hole in the heart, is marked by an atypical hole between the heart’s two upper chambers. In newborn babies who develop a ventricular septal defect, a hole exists between between the heart’s two lower chambers. Omphalocele is a birth defect in which the newborn baby’s abdominal organs protrude from the belly button.

Carey Danis & Lowe Zoloft birth defects lawyers are currently taking Zoloft birth defects cases. For a free legal evaluation of your case and for assistance with filing a Zoloft birth defects lawsuit, contact Carey Danis & Lowe by calling 800.721.2519 or by submitting a personal injury claim form.

NuvaRing Lawsuit News: NuvaRing Lawsuits Recently Filed in the U.S. District Court for the Southern District of Illinois

By | NuvaRing, Pharmaceutical litigation, Uncategorized

nuvaringAccording to a recent Madison-St. Clair Record article, NuvaRing lawsuits have recently been filed in the U.S. District Court for the Southern District of Illinois charging five defendants, among them Organon USA, with failure to properly warn healthcare providers and patients about risks of NuvaRing use.

Health complications commonly cited with the use of the NuvaRing contraceptive device include blood clots, deep vein thrombosis (DVT), stroke, heart attack, pulmonary embolism, blood clots, and in some cases, death. According to a Danish study published in May 2012 in the British Medical Journal, researchers discovered that women using a vaginal ring contraceptive device, such as the NuvaRing, experienced a significantly increased risk of developing blood clots.

In addition to the NuvaRing lawsuits in the U.S. District Court in Illinois, there is also a NuvaRing multidistrict litigation (MDL), known as In re: NuvaRing Products Liability Litigation MDL No. 1964, which is being heard in the U.S. District Court of the Eastern District of Missouri. The NuvaRing MDL is being presided over by U.S. District Judge Rodney W. Sippel.

The Madison-St. Clair Record article has deemed the NuvaRing lawsuits recently filed in Illinois “tag-along” lawsuits, meaning they will be significantly influenced by the NuvaRing MDL. NuvaRing attorneys at Carey Danis & Lowe are interested in following the cases in both U.S. District Courts.

Carey Danis & Lowe NuvaRing lawyers continue to hear from women who have been injured by the NuvaRing contraceptive device. Furthermore, they are currently offering free legal evaluations of NuvaRing cases, and can assist in filing a NuvaRing lawsuit.

If you or someone you love has been injured by Organon and Merck’s NuvaRing contraceptive device, contact a pharmaceutical product liability lawyer at Carey Danis & Lowe today. Call Carey Danis & Lowe at 800.721.2519 or submit a personal injury claim form.

Carey Danis & Lowe Evaluating Zoloft Cases and Offers an Update on Zoloft Lawsuits in Zoloft MDL No. 2342

By | Pharmaceutical litigation, Uncategorized, Zoloft

Published January 14, 2013 by PR Web

St. Louis, Missouri (PRWEB) January 14, 2013

Zoloft MDL Updates: Zoloft MDL No. 2342 Progresses with Order to Submit Initial Discovery Zoloft Birth Defect CasesZoloft lawsuits have been consolidated into a Multi-District Litigation in the U.S. District Court for the Eastern District of Pennsylvania. Judge Cynthia M. Rufe is presiding over the Zoloft MDL.

As to recent developments in the Zoloft MDL, on January 2, 2013, Judge Rufe sent forth Pretrial Order No. 16. Fundamentally, the Pretrial Order outlines how to deliver responses in the MDL. The court document imparts detailed information as to “the procedure for filing responses to all civil actions that are or become consolidated in MDL No. 2342”.*

The Pretrial Order goes on to supply information on how the defendants, Pfizer Inc., Greenstone LLC, and Pfizer International LLC, shall go about filing a Master Short-Form Answer. In essence, the Master-Short Form Answer and Affirmative Defense is the defendants’ response to the claims of the plaintiffs.

According to the Pretrial Order, the Defendants will only have the opportunity to file one Master Short-Form Answer, and in doing so can address any and all charges made against them in each of the cases consolidated in the Zoloft MDL. As the document will stand as their initial response to allegations, Pfizer and Greenstone can deny the plaintiffs’ allegations, and in so doing, they can lay out a defense.

If relying upon information supplied in a recent report, there are quite a number of Zoloft cases in the MDL, and therefore each of these cases will necessitate address in the defense’s response. A Florida attorney who sits on the Plaintiffs’ Steering Committee (PSC), Bryan F. Aylstock, recently submitted a report late last year regarding the status of the Zoloft MDL. The legal journal, The Madison-St. Clair Record, stated that according to information contained in Alystock’s report, there are over 250 cases that have been consolidated into the Zoloft MDL.*

Plaintiffs in the Zoloft MDL have filed lawsuits against Pfizer, the manufacturer of Zoloft, claiming that the antidepressant drug, classified as a selective serotonin re-uptake inhibitor (SSRI), causes birth defects in newborn children when taken by women during pregnancy.

In a separate Zoloft lawsuit being heard in the Wayne County Circuit Court in West Virginia, nineteen plaintiffs, who are the children of mothers who claimed to have taken Zoloft during pregnancy, filed their lawsuit alleging that exposure to Zoloft in the womb resulted in the development of their birth defects.

According to the legal journal, The West Virginia Record, the plaintiffs identified these Zoloft linked birth defects as heart defects, such as atrial septal defects and holes in the heart, persistent pulmonary hypertension of the newborn (PPHN), skull and facial deformations, and a number of other congenital birth defects related to Zoloft exposure in utero.*

Lawyers at Carey Danis & Lowe are currently evaluating Zoloft cases, and they are offering legal consultations to those individuals who claim to have been harmed by the use of Zoloft during pregnancy. For more information about filing a Zoloft lawsuit, and specifically one related to Zoloft and birth defects, contact a lawyer at Carey Danis & Lowe by calling 800-721-2519.